Leo Pharma Inc.

NJ · United States · Reporting entity ID 100000000258

Total reported 2019–2025

$18.4M

#339 of 2,960 reporting companies — 0% of all reported industry payments

$16.6M in general payments across 217,628 records, plus $1.78M in research funding across 37 records.

How it breaks down

General payments $16,632,614

Research funding $1,780,746

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.